Search

Pharmagest Interactive

Atidarymo kaina

0

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai

By Trading Economics

Pajamos

17M

Pardavimai

116M

P/E

Sektoriaus vid.

14.54

Dividendų pajamingumas

3.54

Pelno marža

14.879

Darbuotojai

1,400

EBITDA

116M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.54%

Kitas uždarbis

2026-03-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

522M

Ankstesnė atidarymo kaina

0

Ankstesnė uždarymo kaina

0

Pharmagest Interactive Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-04 23:39; UTC

Karštos akcijos

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

2026-03-04 23:20; UTC

Uždarbis

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

2026-03-04 21:43; UTC

Uždarbis

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

2026-03-04 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise After Recent Selloffs -- Market Talk

2026-03-04 23:33; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

2026-03-04 23:24; UTC

Rinkos pokalbiai

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy 4Q EPS C$2.86 >VET

2026-03-04 22:04; UTC

Rinkos pokalbiai

RBA Slipping Behind The Curve On Rates -- Market Talk

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Rev $66.8M >LAC

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Loss/Shr 52c >LAC

2026-03-04 21:52; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:50; UTC

Uždarbis

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

2026-03-04 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q Rev $165.2M >BULL

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q EPS 1c >BULL

2026-03-04 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-04 21:45; UTC

Rinkos pokalbiai

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

2026-03-04 21:40; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:36; UTC

Svarbiausios naujienos

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

2026-03-04 21:27; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:17; UTC

Rinkos pokalbiai

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

2026-03-04 21:16; UTC

Uždarbis

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q EPS $1.50 >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Net $7.35B >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Rev $19.31B >AVGO

Pharmagest Interactive Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat